All In Biotech

Drug Trial Radar · NCT06651541

Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder

Phase 2 Parallel Clinical Study to Evaluate the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Gel Form Applied to Women With Sexual Arousal Disorder

Last checked: Nov 19, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 174 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

174

Planned (sponsor's estimate)

Start

Jul 1, 2026

Primary completion

Jun 30, 2027

Study completion Jul 31, 2027

Sponsor

Lead sponsor
Biozeus Biopharmaceutical S.A.Industry
Sponsor type
Industry
First posted
Oct 21, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 21 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder

Conditions

  • Female Sexual Arousal Disorder
  • Female Sexual Dysfunction (FSD)

Interventions

  • BZ371A (0.5 ml)Drug

    Formulation with the active ingredient

  • Placebo (0.5 ml)Drug

    Formulation without the active ingredient

  • Placebo (1.0 ml)Drug

    Formulation without the active ingredient

  • BZ371A (1.0 ml)Drug

    Formulation with the active ingredient

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy in increasing arousalTime frame: Baseline, 4 weeks and 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ambulatório Jenny Farias do Hospital das Clínicas da UFMG

    Belo Horizonte, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.